ETF Foundry
DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.
profitability factor · long-only model fund

Foundry ChTax Industry-Neutral Factor ETF

ETF Foundry Research (hypothetical) · rebalanced monthly

FCHRHYPOTHETICAL MODEL
Since ’99
−11%
Expense Ratio
0.35%
placeholder
Holdings
280
cap-weighted
Inception
Jan 2020
placeholder
Full Sharpe
0.03
Ann. Return (LS)
0.3%
Ann. Volatility
12.0%
Max Drawdown
-65.4%
Test Sharpe ’19–26
0.05
Test FF5 α (ann.)
-0.6%
vs Fama-French 5
Test FF5 α t-stat
-0.13
not significant
Monthly turnover
18%
of the long leg, per rebalance
Cumulative return (LS)
-11%
over 331 months
This fund holds the long leg only
Long leg Sharpe
0.61
what this fund holds
Long leg ann. return
12.0%
buyable, long-only
Long-short Sharpe
0.03
requires shorting
Bottom bucket ann. return
11.7%
the basket shorted

Every other metric on this page is the long-shortstrategy, which needs a short book. This fund is the long leg alone, so these are the figures for what it actually holds. The bottom-bucket number is that basket’s own return — not short P&L.

Hypothetical growth of $1 — long-short backtest

Gross of the placeholder expense ratio and trading costs · not investor results

331 months

Holdings

Every constituent of the long leg — sort, search or filter by sector

280 of 280 · 100.0% of book
TickerCompanySectorMarket capWeight
1NVDA
NVIDIA CORPTechnology$4.91T
37.18%
2META
META PLATFORMS INCCommunication Services$1.64T
12.42%
3LLY
ELI LILLY & COHealthcare$1.11T
8.41%
4MU
MICRON TECHNOLOGY INCTechnology$958.80B
7.26%
5ABBV
ABBVIE INCHealthcare$449.63B
3.41%
6KLAC
KLA CORPTechnology$277.91B
2.11%
7TMO
THERMO FISHER SCIENTIFIC INCHealthcare$197.88B
1.50%
8AMGN
AMGEN INCHealthcare$197.69B
1.50%
9ABT
ABBOTT LABORATORIESHealthcare$175.37B
1.33%
10GILD
GILEAD SCIENCES INCHealthcare$166.72B
1.26%
11WDC
WESTERN DIGITAL CORPTechnology$164.49B
1.25%
12UBER
UBER TECHNOLOGIES INCTechnology$147.50B
1.12%
13DHR
DANAHER CORPHealthcare$144.26B
1.09%
14PFE
PFIZER INCHealthcare$142.77B
1.08%
15APP
APPLOVIN CORPTechnology$142.62B
1.08%
16SCCO
SOUTHERN COPPER CORPBasic Materials$142.48B
1.08%
17BMY
BRISTOL MYERS SQUIBB COHealthcare$124.04B
0.94%
18VRTX
VERTEX PHARMACEUTICALS INCHealthcare$123.26B
0.93%
19TT
TRANE TECHNOLOGIES PLCBasic Materials$103.89B
0.79%
20NEM
NEWMONT CORPBasic Materials$95.76B
0.73%
21REGN
REGENERON PHARMACEUTICALS INCHealthcare$70.94B
0.54%
22MPWR
MONOLITHIC POWER SYSTEMS INCTechnology$64.46B
0.49%
23FIX
COMFORT SYSTEMS USA INCIndustrials$58.93B
0.45%
24CTVA
CORTEVA INCBasic Materials$58.39B
0.44%
25COHR
COHERENT CORPTechnology$54.31B
0.41%
26KEYS
KEYSIGHT TECHNOLOGIES INCTechnology$53.99B
0.41%
27ROK
ROCKWELL AUTOMATION INCIndustrials$51.39B
0.39%
28TER
TERADYNE INCTechnology$50.46B
0.38%
29XYZ
BLOCK INCTechnology$47.58B
0.36%
30IDXX
IDEXX LABORATORIES INCHealthcare$44.76B
0.34%
31RVMD
REVOLUTION MEDICINES INCHealthcare$39.58B
0.30%
32A
AGILENT TECHNOLOGIES INCHealthcare$37.13B
0.28%
33ROP
ROPER TECHNOLOGIES INCTechnology$36.65B
0.28%
34WAT
WATERS CORPHealthcare$36.23B
0.27%
35ALNY
ALNYLAM PHARMACEUTICALS INCHealthcare$35.71B
0.27%
36ONC
BEONE MEDICINES LTDHealthcare$34.68B
0.26%
37RPRX
ROYALTY PHARMA PLCHealthcare$33.50B
0.25%
38MSTR
STRATEGY INCTechnology$33.24B
0.25%
39KHC
KRAFT HEINZ COConsumer Defensive$30.69B
0.23%
40FICO
FAIR ISAAC CORPTechnology$29.15B
0.22%
41ILMN
ILLUMINA INCHealthcare$28.24B
0.21%
42MTD
METTLER TOLEDO INTERNATIONAL INCHealthcare$26.47B
0.20%
43ROIV
ROIVANT SCIENCES LTDHealthcare$24.82B
0.19%
44MRNA
MODERNA INCHealthcare$24.53B
0.19%
45INSM
INSMED INCHealthcare$23.48B
0.18%
46VLTO
VERALTO CORPIndustrials$23.04B
0.17%
47STZ
CONSTELLATION BRANDS INCConsumer Defensive$22.69B
0.17%
48MKSI
MKS INCTechnology$21.93B
0.17%
49FTV
FORTIVE CORPTechnology$18.83B
0.14%
50NBIX
NEUROCRINE BIOSCIENCES INCHealthcare$17.18B
0.13%
51LSCC
LATTICE SEMICONDUCTOR CORPTechnology$17.16B
0.13%
52ONTO
ONTO INNOVATION INCTechnology$13.92B
0.11%
53EVR
EVERCORE INCFinancial Services$13.21B
0.10%
54PINS
PINTEREST INCCommunication Services$13.00B
0.10%
55DT
DYNATRACE INCTechnology$12.94B
0.10%
56TRMB
TRIMBLE INCTechnology$12.29B
0.09%
57RVTY
REVVITY INCHealthcare$12.29B
0.09%
58PODD
INSULET CORPHealthcare$11.36B
0.09%
59TECH
BIO-TECHNE CORPHealthcare$11.29B
0.09%
60SMMT
SUMMIT THERAPEUTICS INCHealthcare$10.72B
0.08%
61CGNX
COGNEX CORPTechnology$10.66B
0.08%
62HII
HUNTINGTON INGALLS INDUSTRIES INCIndustrials$10.60B
0.08%
63ARWR
ARROWHEAD PHARMACEUTICALS INCHealthcare$10.47B
0.08%
64APGE
APOGEE THERAPEUTICS INCHealthcare$10.10B
0.08%
65DOCU
DOCUSIGN INCTechnology$10.07B
0.08%
66NUVL
NUVALENT INCHealthcare$9.79B
0.07%
67HL
HECLA MINING COBasic Materials$9.61B
0.07%
68HALO
HALOZYME THERAPEUTICS INCHealthcare$9.23B
0.07%
69IONS
IONIS PHARMACEUTICALS INCHealthcare$8.99B
0.07%
70BRKR
BRUKER CORPHealthcare$8.86B
0.07%
71CRNX
CRINETICS PHARMACEUTICALS INCHealthcare$8.84B
0.07%
72CHWY
CHEWY INCConsumer Cyclical$8.57B
0.06%
73RGEN
REPLIGEN CORPHealthcare$8.31B
0.06%
74BIO
BIO-RAD LABORATORIES INCHealthcare$8.15B
0.06%
75IBRX
IMMUNITYBIO INCHealthcare$8.04B
0.06%
76CAVA
CAVA GROUP INCConsumer Cyclical$8.02B
0.06%
77AVTR
AVANTOR INCBasic Materials$7.56B
0.06%
78YOU
CLEAR SECURE INCTechnology$7.49B
0.06%
79PBF
PBF ENERGY INCEnergy$7.42B
0.06%
80RYTM
RHYTHM PHARMACEUTICALS INCHealthcare$7.31B
0.06%
81CROX
CROCS INCConsumer Cyclical$6.81B
0.05%
82XENE
XENON PHARMACEUTICALS INCHealthcare$6.60B
0.05%
83ST
SENSATA TECHNOLOGIES HOLDING PLCTechnology$6.55B
0.05%
84BYD
BOYD GAMING CORPConsumer Cyclical$6.52B
0.05%
85APPF
APPFOLIO INCTechnology$6.36B
0.05%
86SRRK
SCHOLAR ROCK HOLDING CORPHealthcare$6.33B
0.05%
87LGND
LIGAND PHARMACEUTICALS INCHealthcare$6.08B
0.05%
88SEZL
SEZZLE INCFinancial Services$5.87B
0.04%
89TWST
TWIST BIOSCIENCE CORPHealthcare$5.84B
0.04%
90CAR
AVIS BUDGET GROUP INCIndustrials$5.67B
0.04%
91TXG
10X GENOMICS INCHealthcare$5.55B
0.04%
92GTLB
GITLAB INCTechnology$5.53B
0.04%
93PIPR
PIPER SANDLER COMPANIESFinancial Services$5.42B
0.04%
94TVTX
TRAVERE THERAPEUTICS INCHealthcare$5.27B
0.04%
95KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL PLCHealthcare$4.92B
0.04%
96CNX
CNX RESOURCES CORPEnergy$4.71B
0.04%
97SITE
SITEONE LANDSCAPE SUPPLY INCIndustrials$4.60B
0.03%
98SYNA
SYNAPTICS INCTechnology$4.41B
0.03%
99BMI
BADGER METER INCTechnology$4.36B
0.03%
100VKTX
VIKING THERAPEUTICS INCHealthcare$4.31B
0.03%
101VNT
VONTIER CORPTechnology$4.25B
0.03%
102BOX
BOX INCTechnology$4.22B
0.03%
103MIR
MIRION TECHNOLOGIES INCIndustrials$4.00B
0.03%
104FOUR
SHIFT4 PAYMENTS INCTechnology$3.99B
0.03%
105CRK
COMSTOCK RESOURCES INCEnergy$3.92B
0.03%
106CPRX
CATALYST PHARMACEUTICALS INCHealthcare$3.85B
0.03%
107PARR
PAR PACIFIC HOLDINGS INCEnergy$3.82B
0.03%
108RLAY
RELAY THERAPEUTICS INCHealthcare$3.81B
0.03%
109ITRI
ITRON INCTechnology$3.81B
0.03%
110DNLI
DENALI THERAPEUTICS INCHealthcare$3.70B
0.03%
111PVH
PVH CORPConsumer Cyclical$3.60B
0.03%
112ARQT
ARCUTIS BIOTHERAPEUTICS INCHealthcare$3.56B
0.03%
113OGN
ORGANON & COHealthcare$3.55B
0.03%
114GPCR
STRUCTURE THERAPEUTICS INCHealthcare$3.45B
0.03%
115WDFC
WD 40 COBasic Materials$3.31B
0.03%
116PPLI
PEOPLE INCCommunication Services$3.31B
0.03%
117AAP
ADVANCE AUTO PARTS INCConsumer Cyclical$3.19B
0.02%
118UAA
UNDER ARMOUR INCConsumer Cyclical$3.17B
0.02%
119CARG
CARGURUS INCConsumer Cyclical$3.16B
0.02%
120TRN
TRINITY INDUSTRIES INCIndustrials$2.90B
0.02%
121RARE
ULTRAGENYX PHARMACEUTICAL INCHealthcare$2.88B
0.02%
122TDC
TERADATA CORPTechnology$2.87B
0.02%
123BKV
BKV CORPEnergy$2.84B
0.02%
124WU
WESTERN UNION COFinancial Services$2.77B
0.02%
125VERA
VERA THERAPEUTICS INCHealthcare$2.76B
0.02%
126GPOR
GULFPORT ENERGY CORPEnergy$2.75B
0.02%
127NGVT
INGEVITY CORPBasic Materials$2.66B
0.02%
128ATAI
ATAIBECKLEY INCHealthcare$2.66B
0.02%
129TARS
TARSUS PHARMACEUTICALS INCHealthcare$2.58B
0.02%
130GRDN
GUARDIAN PHARMACY SERVICES INCHealthcare$2.57B
0.02%
131AEHR
AEHR TEST SYSTEMSTechnology$2.55B
0.02%
132QURE
UNIQURE NVHealthcare$2.54B
0.02%
133PBI
PITNEY BOWES INCIndustrials$2.51B
0.02%
134CMPR
CIMPRESS PLCCommunication Services$2.49B
0.02%
135SLS
SELLAS LIFE SCIENCES GROUP INCHealthcare$2.45B
0.02%
136COHU
COHU INCTechnology$2.41B
0.02%
137VCEL
VERICEL CORPHealthcare$2.38B
0.02%
138BCRX
BIOCRYST PHARMACEUTICALS INCHealthcare$2.36B
0.02%
139BHVN
BIOHAVEN LTDHealthcare$2.32B
0.02%
140HE
HAWAIIAN ELECTRIC INDUSTRIES INCUtilities$2.32B
0.02%
141NKTR
NEKTAR THERAPEUTICSHealthcare$2.31B
0.02%
142HCI
HCI GROUP INCFinancial Services$2.27B
0.02%
143NEOG
NEOGEN CORPHealthcare$2.24B
0.02%
144IOVA
IOVANCE BIOTHERAPEUTICS INCHealthcare$2.23B
0.02%
145GT
GOODYEAR TIRE & RUBBER COConsumer Cyclical$2.10B
0.02%
146SNDX
SYNDAX PHARMACEUTICALS INCHealthcare$2.02B
0.02%
147ADMA
ADMA BIOLOGICS INCHealthcare$2.02B
0.02%
148INOD
INNODATA INCTechnology$1.99B
0.02%
149ABCL
ABCELLERA BIOLOGICS INCHealthcare$1.97B
0.01%
150AMLX
AMYLYX PHARMACEUTICALS INCHealthcare$1.97B
0.01%
151HRMY
HARMONY BIOSCIENCES HOLDINGS INCHealthcare$1.96B
0.01%
152DMRA
DAMORA THERAPEUTICS INCHealthcare$1.94B
0.01%
153TYRA
TYRA BIOSCIENCES INCHealthcare$1.91B
0.01%
154PRG
PROG HOLDINGS INCIndustrials$1.86B
0.01%
155ANIP
ANI PHARMACEUTICALS INCHealthcare$1.80B
0.01%
156IMCR
IMMUNOCORE HOLDINGS PLCHealthcare$1.78B
0.01%
157BL
BLACKLINE INCTechnology$1.78B
0.01%
158INVX
INNOVEX INTERNATIONAL INCEnergy$1.77B
0.01%
159HROW
HARROW INCHealthcare$1.74B
0.01%
160TSHA
TAYSHA GENE THERAPIES INCHealthcare$1.71B
0.01%
161ANAB
ANAPTYSBIO INCHealthcare$1.69B
0.01%
162INVA
INNOVIVA INCHealthcare$1.60B
0.01%
163PUMP
PROPETRO HOLDING CORPEnergy$1.59B
0.01%
164VIR
VIR BIOTECHNOLOGY INCHealthcare$1.59B
0.01%
165IDT
IDT CORPCommunication Services$1.57B
0.01%
166XERS
XERIS BIOPHARMA HOLDINGS INCHealthcare$1.52B
0.01%
167MLKN
MILLERKNOLL INCConsumer Cyclical$1.49B
0.01%
168ALNT
ALLIENT INCTechnology$1.49B
0.01%
169MLTX
MOONLAKE IMMUNOTHERAPEUTICSHealthcare$1.45B
0.01%
170DMC
DEL MONTE CORPConsumer Defensive$1.40B
0.01%
171CXM
SPRINKLR INCTechnology$1.37B
0.01%
172BV
BRIGHTVIEW HOLDINGS INCIndustrials$1.35B
0.01%
173PAHC
PHIBRO ANIMAL HEALTH CORPHealthcare$1.35B
0.01%
174XNCR
XENCOR INCHealthcare$1.30B
0.01%
175TTI
TETRA TECHNOLOGIES INCEnergy$1.25B
0.01%
176TDAY
USA TODAY CO INCConsumer Cyclical$1.25B
0.01%
177HLF
HERBALIFE LTDConsumer Defensive$1.24B
0.01%
178NPKI
NPK INTERNATIONAL INCEnergy$1.21B
0.01%
179AVO
MISSION PRODUCE INCConsumer Defensive$1.20B
0.01%
180QDEL
QUIDELORTHO CORPHealthcare$1.19B
0.01%
181COLL
COLLEGIUM PHARMACEUTICAL INCHealthcare$1.17B
0.01%
182SDGR
SCHRODINGER INCHealthcare$1.14B
0.01%
183SVRA
SAVARA INCHealthcare$1.13B
0.01%
184CAPR
CAPRICOR THERAPEUTICS INCHealthcare$1.13B
0.01%
185NUTX
NUTEX HEALTH INCHealthcare$1.12B
0.01%
186WVE
WAVE LIFE SCIENCES LTDHealthcare$1.12B
0.01%
187UPWK
UPWORK INCIndustrials$1.12B
0.01%
188EYPT
EYEPOINT INCHealthcare$1.12B
0.01%
189JBIO
JADE BIOSCIENCES INCHealthcare$1.03B
0.01%
190AVTX
AVALO THERAPEUTICS INCHealthcare$1.02B
0.01%
191FBRX
FORTE BIOSCIENCES INCHealthcare$1.00B
0.01%
192VOR
VOR BIOPHARMA INCHealthcare$980M
0.01%
193TBPH
THERAVANCE BIOPHARMA INCHealthcare$873M
0.01%
194SLDB
SOLID BIOSCIENCES INCHealthcare$859M
0.01%
195MATW
MATTHEWS INTERNATIONAL CORPIndustrials$857M
0.01%
196CYRX
CRYOPORT INCIndustrials$832M
0.01%
197TRNS
TRANSCAT INCIndustrials$821M
0.01%
198RJET
REPUBLIC AIRWAYS HOLDINGS INCIndustrials$806M
0.01%
199OPFI
OPPFI INCFinancial Services$801M
0.01%
200HNRG
HALLADOR ENERGY COBasic Materials$753M
0.01%
201IBTA
IBOTTA INCTechnology$734M
0.01%
202AURA
AURA BIOSCIENCES INCHealthcare$723M
0.01%
203OMER
OMEROS CORPHealthcare$701M
0.01%
204CRMD
CORMEDIX INCHealthcare$661M
0.01%
205FEIM
FREQUENCY ELECTRONICS INCTechnology$650M
0.00%
206TCMD
TACTILE SYSTEMS TECHNOLOGY INCHealthcare$648M
0.00%
207CWH
CAMPING WORLD HOLDINGS INCConsumer Cyclical$637M
0.00%
208TECX
TECTONIC THERAPEUTIC INCHealthcare$615M
0.00%
209NRDS
NERDWALLET INCCommunication Services$609M
0.00%
210GYRE
GYRE THERAPEUTICS INCHealthcare$587M
0.00%
211MYGN
MYRIAD GENETICS INCHealthcare$584M
0.00%
212STTK
SHATTUCK LABS INCHealthcare$577M
0.00%
213RYAM
RAYONIER ADVANCED MATERIALS INCBasic Materials$555M
0.00%
214RLMD
RELMADA THERAPEUTICS INCHealthcare$550M
0.00%
215ELA
ENVELA CORPConsumer Cyclical$547M
0.00%
216MLAB
MESA LABORATORIES INCTechnology$541M
0.00%
217KELYA
KELLY SERVICES INCIndustrials$531M
0.00%
218ZURA
ZURA BIO LTDHealthcare$518M
0.00%
219XOMA
XOMA ROYALTY CORPHealthcare$504M
0.00%
220JOUT
JOHNSON OUTDOORS INCConsumer Cyclical$485M
0.00%
221SGMT
SAGIMET BIOSCIENCES INCHealthcare$479M
0.00%
222MTW
MANITOWOC CO INCIndustrials$468M
0.00%
223PRTA
PROTHENA CORP PUBLIC LTD COHealthcare$453M
0.00%
224IDR
IDAHO STRATEGIC RESOURCES INCBasic Materials$449M
0.00%
225FSTR
FOSTER L B COIndustrials$439M
0.00%
226PBYI
PUMA BIOTECHNOLOGY INCHealthcare$434M
0.00%
227CBIO
CRESCENT BIOPHARMA INCHealthcare$407M
0.00%
228MCFT
MASTERCRAFT BOAT HOLDINGS INCConsumer Cyclical$407M
0.00%
229ENTA
ENANTA PHARMACEUTICALS INCHealthcare$400M
0.00%
230ABEO
ABEONA THERAPEUTICS INCHealthcare$399M
0.00%
231CRNC
CERENCE INCTechnology$390M
0.00%
232EOLS
EVOLUS INCHealthcare$377M
0.00%
233SLP
SIMULATIONS PLUS INCHealthcare$369M
0.00%
234ZNTL
ZENTALIS PHARMACEUTICALS INCHealthcare$364M
0.00%
235NATR
NATURES SUNSHINE PRODUCTS INCConsumer Defensive$359M
0.00%
236LE
LANDS' END INCConsumer Cyclical$357M
0.00%
237ISSC
INNOVATIVE SOLUTIONS & SUPPORT INCIndustrials$330M
0.00%
238VNDA
VANDA PHARMACEUTICALS INCHealthcare$327M
0.00%
239BKTI
BK TECHNOLOGIES CORPTechnology$307M
0.00%
240ALCO
ALICO INCConsumer Defensive$304M
0.00%
241TKNO
ALPHA TEKNOVA INCHealthcare$291M
0.00%
242UCFI
CN HEALTHY FOOD TECH GROUP CORPConsumer Defensive$288M
0.00%
243MASS
908 DEVICES INCHealthcare$278M
0.00%
244OPRT
OPORTUN FINANCIAL CORPFinancial Services$274M
0.00%
245TRDA
ENTRADA THERAPEUTICS INCHealthcare$268M
0.00%
246ZSQR
Z SQUARED INCHealthcare$260M
0.00%
247SRZN
SURROZEN INCHealthcare$255M
0.00%
248SENS
SENSEONICS HOLDINGS INCHealthcare$214M
0.00%
249TNXP
TONIX PHARMACEUTICALS HOLDING CORPHealthcare$198M
0.00%
250SRI
STONERIDGE INCConsumer Cyclical$197M
0.00%
251EAF
GRAFTECH INTERNATIONAL LTDIndustrials$181M
0.00%
252KRRO
KORRO BIO INCHealthcare$177M
0.00%
253INSE
INSPIRED ENTERTAINMENT INCConsumer Cyclical$174M
0.00%
254ARCT
ARCTURUS THERAPEUTICS HOLDINGS INCHealthcare$172M
0.00%
255INTT
INTEST CORPTechnology$169M
0.00%
256LENZ
LENZ THERAPEUTICS INCHealthcare$162M
0.00%
257OWLT
OWLET INCHealthcare$162M
0.00%
258PED
PEDEVCO CORPEnergy$161M
0.00%
259LGCY
LEGACY EDUCATION INCConsumer Defensive$154M
0.00%
260UNCY
UNICYCIVE THERAPEUTICS INCHealthcare$144M
0.00%
261HURC
HURCO COMPANIES INCIndustrials$142M
0.00%
262VTVT
VTV THERAPEUTICS INCHealthcare$130M
0.00%
263CUE
CUE BIOPHARMA INCHealthcare$126M
0.00%
264SPRB
SPRUCE BIOSCIENCES INCHealthcare$120M
0.00%
265MED
MEDIFAST INCConsumer Cyclical$114M
0.00%
266LAKE
LAKELAND INDUSTRIES INCConsumer Cyclical$113M
0.00%
267KEQU
KEWAUNEE SCIENTIFIC CORPConsumer Cyclical$109M
0.00%
268CPIX
CUMBERLAND PHARMACEUTICALS INCHealthcare$103M
0.00%
269ICCC
IMMUCELL CORPHealthcare$101M
0.00%
270VRCA
VERRICA PHARMACEUTICALS INCHealthcare$96M
0.00%
271OPXS
OPTEX SYSTEMS HOLDINGS INCIndustrials$89M
0.00%
272GEOS
GEOSPACE TECHNOLOGIES CORPEnergy$88M
0.00%
273RLYB
RALLYBIO CORPHealthcare$87M
0.00%
274CSBR
CHAMPIONS ONCOLOGY INCHealthcare$85M
0.00%
275FRMM
FORUM MARKETS INCHealthcare$83M
0.00%
276ATRA
ATARA BIOTHERAPEUTICS INCHealthcare$76M
0.00%
277SCLX
SCILEX HOLDING COHealthcare$72M
0.00%
278XLO
XILIO THERAPEUTICS INCHealthcare$53M
0.00%
279ACFN
ACORN ENERGY INCTechnology$51M
0.00%
280TIL
INSTIL BIO INCHealthcare$50M
0.00%

Full long-leg book as of July 2026 · cap-weighted · total market cap $13.20T. Hypothetical model holdings — not a registered fund’s portfolio.

Sector Breakdown

10 sectors
Technology
54.2%
Healthcare
27.4%
Communication Services
12.6%
Basic Materials
3.2%
Industrials
1.3%
Consumer Defensive
0.4%
Consumer Cyclical
0.4%
Energy
0.2%
Financial Services
0.2%
Utilities
0.0%

Portfolio Style

Size × value map of the long-leg book

280 classified
Value
Blend
Growth
Large
Mid
Small
2%4
31%30
64%53
<1%28
<1%26
1%42
<1%28
<1%35
<1%12

Share of long-leg capital by market cap × book-to-market, using terciles of the 3,283-name universe at July 2026. Rows: Large ≥ $5.2B, Small < $819M. Columns: Value ≥ 0.62, Growth < 0.34 B/M. The dot marks the capital-weighted centroid of the book — 99% toward Large, 81% toward Growth. +1% unclassified (22 missing size/value). Hypothetical holdings — descriptive, not realized P&L.

Tilt over time
Size tilt99% → Large
SmallLarge
Value ↔ growth tilt81% → Growth
ValueGrowth

Capital-weighted centroid of the long leg, December 1998July 2026; the right-hand end is the same value as the box’s dot. 280 names now. The faded start covers early months with a much thinner universe. Hypothetical holdings — descriptive, not P&L.

Constraint checks

How this book measures against the concentration and liquidity rules — as implemented here

How this book was built

These are UNCONSTRAINED factor sleeves: the construction pipeline sorts on a signal and cap-weights the top bucket, applying no issuer cap, no industry cap and no liquidity screen beyond the universe filter. A failing test therefore reports a constraint that was never applied during construction — it is not a defect in the strategy and not an error in the data. The same signal can be solved subject to these constraints.

Passed
1
Failed
4
Not tested
2
Independent checks
7

7 independent checks plus 1 arithmetically implied by another check (RIC / IRC 851(b)(3)(A) 50% bucket), which is reported separately so the tally cannot overstate scrutiny.

2 of 7 checks could not be tested. Those are neither passes nor failures — they are gaps in what the data can answer, and they are excluded from the passed count above rather than folded into it.

  • With respect to 75% of total assets, no more than 5% may be invested in the securities of any one issuer.

    Required
    >= 75.0%
    Actual
    54.7%
    Margin
    -20.3%
  • No more than 25% of total assets may be invested in the securities of any one issuer.

    Required
    <= 25.0%
    Actual
    37.2%
    Margin
    -12.2%
  • The fund will not concentrate: no more than 25% of total assets in any one industry (excluding government securities and cash items).

    Required
    <= 25.0%
    Actual
    45.1%
    Margin
    -20.1%
  • Days required to liquidate the largest position at 20% of one day's dollar volume.

    Required
    <= 7.0 days
    Actual
    unbounded
    Margin
Reported separately — arithmetically implied

Engineering approximation of the cited rules for a DRAFT / HYPOTHETICAL model portfolio that is not a registered fund. This reports whether the portfolio passes the stated test AS IMPLEMENTED HERE; it is not a compliance opinion and is not a statement that any fund is compliant. Real filings need securities counsel.

No verdict sits within 1.0pp of its limit.

Data version — panel=20260719T025334 rows=2239262 asof=202607 issuers=20260719T014536 rates=20260804T224700

Measured on the 2026-07 formation date across 280 holdings (cap-weighted). A different formation date can produce different verdicts.

Derivatives risk (Rule 18f-4)

Whether this long-only book is subject to the VaR tests at all

This assessment describes the long-only book this fund holds — the top bucket only.

Governing rule
Rule 18f-4(c)(4) limited derivatives user exception

This fund QUALIFIES for the limited-derivatives-user exception, so it is excepted from the VaR tests; the ratio below is informational, not the operative limit.

Limited derivatives user exceptionby construction

Rule 18f-4(c)(4): a fund whose derivatives exposure (gross notional, including the value of assets sold short) is <= 10% of net assets is excepted from the VaR tests and the full derivatives risk management program.

Qualifies
Required
<= 10% of net assets
Exposure
0% of net assets
Margin
+10pp

No confidence interval: this follows from portfolio construction, not from an estimate.

Rule 18f-4(c)(2)(i): fund VaR at 99% over 20 trading days must not exceed 200% of the designated reference portfolio's VaR on the same basis.

Informational — does not govern

This fund is excepted from the VaR tests, so the ratio below is context rather than the operative limit. It is shown because it is still a description of the book’s risk, not because it decides anything.

Measured
1.4 (95% CI 1.0-1.5)
x reference VaR
Limit
2.00x
<= 2.00x reference VaR
Fund VaR
13.2%
99% / 20d
Reference
9.6%
FF5 market (mkt)

historical method · 331 monthly observations · about 3.3 in the 99% tail · paired percentile bootstrap over months

Same test, three estimators
historical
1.37x
within
parametric
1.24x
within
cornish fisher
1.15x
within

The estimators agree, which is mild evidence the number isn’t an artefact of one method.

Engineering approximation of SEC Rule 18f-4 for research display. Not a compliance opinion and not a determination that any fund is compliant. Hypothetical model portfolio, not a registered fund.

The research long-short construction behind this factor does not qualify for this exception — a dollar-neutral book counts its full short notional, which is 100% of net assets against a 10% threshold. This product sidesteps that by holding the long leg alone, which is also why the long-leg Sharpe is reported separately throughout the site.

See the long-short verdict on the factor page →

Since publication

Did the edge survive the paper coming out?

published 2011
Before publication (pre-2011)
0.11
Sharpe · 1.4% p.a.
January 1999December 2011 · 156 mo
Since publication
-0.06
Sharpe · -0.7% p.a.
January 2012July 2026 · 175 mo
Change in Sharpe−0.17the return reversed sign — the published edge now runs the other way

Split at January of the year after the factor was published. The post-publication stretch IS genuinely out-of-sample relative to the original study -- the predictor was public by then -- so it speaks to whether the effect survived being known. Nothing is fitted here, so this is performance SINCE PUBLICATION, not validation of a model. Note the 'pre' side is our data before publication (our panel starts ~1999), NOT the study's original in-sample period, which usually ran decades earlier; a decay figure compares before-vs-after within our sample and is not a comparison against the published result.

Consistency across eras

Is this record broadly durable, or one regime?

26 windows
Positive windows
42%
11 of 26 3-year windows made money
Worst window
-1.16
Sharpe, January 2005 – December 2007
January 1999July 2026
Median Sharpe
-0.33
Dispersion
0.49
Best window
1.03

3-year rolling windows, stepping 1 year (26 windows). Dispersion is the spread of window Sharpes — higher means the record depends more on which era you look at.

Rules-based factors fit no parameters, so these windows are not out-of-sample tests and do not validate a fitted model. They show whether the factor's record is consistent across eras or driven by one regime.

Returns

Long leg is what this fund holds — long-short is shown for reference

since January 1999
Trailing
PeriodLong legLong-short
1 yearcum.30.3%-2.5%
3 yearsp.a.33.4%9.6%
5 yearsp.a.20.2%1.0%
10 yearsp.a.16.8%-0.3%
Since inceptionp.a.10.5%-0.4%
Calendar years
YearLong legLong-short
20267 mo3.6%-15.5%
202536.3%21.3%
202459.5%27.5%
202329.4%-3.8%
2022-16.4%-12.1%
202114.7%-8.4%
202018.9%2.1%
201920.9%-4.5%
2018-2.3%2.0%
201718.5%4.7%
20164.3%-16.5%
20151.3%4.1%
20148.5%1.8%
201327.3%-10.2%
201217.8%-0.5%
2011-2.1%-5.1%
201029.8%10.4%
200920.8%-16.2%
2008-32.3%12.5%
20078.4%-10.5%
20067.9%-13.3%
20056.7%-0.9%
200416.3%-1.1%
200340.2%1.7%
2002-26.9%1.6%
2001-13.6%-5.5%
2000-18.5%-17.1%
199980.9%76.4%

Long leg = the top bucket this fund holds; long-short additionally shorts the bottom bucket and is not achievable in a long-only vehicle. Trailing figures run through July 2026: 1 year is a plain cumulative 12-month return (cum.), 3 years and longer are annualised (p.a.). Years marked with a month count are partial. These match the fact sheet’s tables by construction. Hypothetical backtest, gross of the placeholder expense ratio and trading costs — not investor results.

Fund Facts

Ticker (pseudo)FCHR
IssuerETF Foundry Research (hypothetical)
SeriesHypothetical Model Portfolio Series (not a registered trust)
Expense ratio0.35% (placeholder)
Inception2020-01-08 (placeholder)
Listing exchangeNot listed (hypothetical)
CUSIPNot applicable (hypothetical model portfolio)
RebalanceMonthly
Holdings as ofJuly 2026
Total mkt cap (long leg)$13.20T

Methodology

The Foundry ChTax Industry-Neutral Factor ETF tracks a rules-based model that ranks liquid U.S. common stocks, industry-neutralized within Fama-French industries, each month by a ChTax signal and holds the top decile with the highest values. Signals are computed from point-in-time Sharadar fundamentals and total-return prices. The portfolio reconstitutes monthly and is cap-weighted within the long leg.

This is a hypothetical model portfolio for research display only — not a registered fund, not an offer, and not investment advice.

Documents (draft — hypothetical)

Auto-generated from the model’s metrics and current holdings. Every document is labeled DRAFT / hypothetical.

Summary Prospectus

Objective, fees, strategy, and key risks.

View →
Prospectus

Full strategy, model methodology, and risks.

View →
Statement of Additional Information

Policies, construction, and governance.

View →
Fact Sheet

One-page snapshot with top holdings.

View →
Daily Holdings

Full current constituent list.

View →

DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.